Tech Company Financing Transactions
Newronika Funding Round
On 2/13/2025, Newronika landed $14.3 million in Series B investment from ENEA Tech Biomedical, Indaco Venture Partners and Innogest Capital.
Transaction Overview
Company Name
Announced On
2/13/2025
Transaction Type
Venture Equity
Amount
$14,300,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to expand the clinical validation and commercialization of its proprietary adaptive DBS system.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Foro Buonaparte, 57
Milan, 20121
Italy
Milan, 20121
Italy
Phone
Website
Email Address
Overview
Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ?e are a multidisciplinary team formed from neuroscience research groups. We involve scientists in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lorenzo Rossi
Browse more venture capital transactions:
Prev: 2/13/2025: Aracor AI venture capital transaction
Next: 2/13/2025: JETSET Pilates venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs